Pharma-Bio Serv (PBSV) Other financing activities (2021 - 2024)

Pharma-Bio Serv's (PBSV) quarterly Other financing activities came in at $1.0 in Q1 2024, down 80.0% on a QoQ basis from $5.0 in Q2 2023.

Pharma-Bio Serv (PBSV) Other financing activities (2021 - 2024) Analysis & Trends

Pharma-Bio Serv (PBSV) has 4 years of Other financing activities data on file, last reported at $1.0 in Q1 2024.

Quarterly Other financing activities changed N/A year-over-year to $1.0 in Q1 2024, while the trailing twelve-month figure through Apr 2024 was $6.0 (down 25.0% YoY) and the FY2023 annual result came in at $5.0, up 66.67% from the prior year.
Other financing activities slipped to $1.0 in Q1 2024, from $5.0 in the prior quarter.
In the past five years, Other financing activities ranged from a high of $5.0 in Q2 2023 to a low of $1.0 in Q1 2024.
A 4-year average of $2.75 and a median of $2.5 in 2021 frame the typical range for Other financing activities.
The widest YoY moves for Other financing activities: up 50.0% in 2022, down 50.0% in 2022.
Tracing PBSV's Other financing activities over 4 years: stood at $2.0 in 2021, then jumped by 50.0% to $3.0 in 2022, then soared by 66.67% to $5.0 in 2023, then tumbled by 80.0% to $1.0 in 2024.
The last three Other financing activities figures came in at $1.0 (Q1 2024), $5.0 (Q2 2023), and $3.0 (Q1 2022), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Veeva Systems	39.72 Bn	32.40 Bn	662.02 Mn
2	BrightSpring Health Services	12.19 Bn	11.64 Bn	492.75 Mn
3	Healthequity	8.79 Bn	8.52 Bn	256.31 Mn
4	10x Genomics	7.31 Bn	6.76 Bn	112.50 Mn
5	Hinge Health	7.10 Bn	6.71 Bn	183.95 Mn
6	MiniMed	5.66 Bn	5.36 Bn	480.00 Mn
7	Waystar Holding	4.76 Bn	4.56 Bn	221.99 Mn
8	Doximity	4.46 Bn	3.77 Bn	132.93 Mn
9	Heartflow	3.66 Bn	3.28 Bn	53.19 Mn
10	Pharma-Bio Serv	12.37 Mn	3.89 Mn	902,041.00

Download Data